Loss ofCDKN2AEnhances the Efficacy of Immunotherapy inEGFR-Mutant Non–Small Cell Lung Cancer

Post time Yesterday 15:42

journal：Cancer Research

Authors：Simeng Wang; Jia-Cheng Lai; Yu Li; Chengfang Tang; Jiajia Lu; Min Han; Xianjiang Ye; Lina Jia; Wei Cui; Jingyu Yang; Chunfu Wu; Lihui Wang

Published date：2025-2-1

DOI：10.1158/0008-5472.can-24-1817

PDF link：https://aacrjournals.org/cancerr ... 017/can-24-1817.pdf

Article link：https://doi.org/10.1158/0008-5472.can-24-1817

Article Source：American Association for Cancer Research (AACR)。

Remark：

Post time Yesterday 23:50

: Waiting for confirmation
If the PDF has not been accepted after 72 hours, the system will automatically adopt it.

[AACR] Loss ofCDKN2AEnhances the Efficacy of Immunotherapy inEGFR-Mutant Non–Small Cell Lung Cancer

Same Category

Latest Reply

Announcement

Daily Top Contributors

[AACR] Loss ofCDKN2AEnhances the Efficacy of Immunotherapy inEGFR-Mutant Non–Small Cell Lung Cancer Copy

Same Category

Latest Reply

Announcement

Daily Top Contributors

[AACR] Loss ofCDKN2AEnhances the Efficacy of Immunotherapy inEGFR-Mutant Non–Small Cell Lung Cancer